As of last year, this also includes the PureWick system. Generally, under DME, Part B will cover male and female external catheters with permanent urinary incontinence as an alternative to ...
Coinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.